Pharmaceutical

SK bioscience to expand vaccine manufacturing plant in South Korea

SK bioscience has broken ground on a significant expansion of its vaccine manufacturing facility, L HOUSE, in South Korea.

Mar 9, 2024 - 18:00
SK bioscience to expand vaccine manufacturing plant in South Korea
SK bioscience has broken ground on a significant expansion of its vaccine manufacturing facility, L HOUSE, in South Korea.
Read the original article

Tags:

Previous Article

Oligonucleotides: Overcoming sustainability challenges with manufacturing

Next Article

Johnson & Johnson acquires Ambrx Biopharma for $2bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Workforce, capacity constraints slow ramp-up of new Alzheimer’s drug Leqembi

STAT+: Workforce, capacity constraints slow ramp-up of ...

Aug 31, 2023

Watch: P-value, an important measurement in clinical trials, explained

Watch: P-value, an important measurement in clinical tr...

Mar 20, 2023

STAT+: Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition

STAT+: Bayer’s promising menopause drug trial results h...

Jan 10, 2024